AlphaMaven AlphaMaven

TILRAY Q1 2027 Earnings Preview: Recent $TLRY Insider Trading, Hedge Fund Activity, and More

Reported by Quiver Quantitative
Oct 6, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Tilray Brands is scheduled to report Q1 2027 earnings after market close on October 8, 2026, with analyst consensus expecting a loss of $0.1640 per share and revenue of $267.77 million for the quarter.
  • • The company delivered record fiscal 2026 revenue and adjusted EBITDA, demonstrating strength across its diversified global platform spanning cannabis, beverage, hospitality, and wellness segments.
  • • Tilray operates as a Nasdaq-listed (TLRY) and TSX-listed consumer packaged goods company positioned at the intersection of beverage, cannabis, and wellness industries.
  • • Recent insider trading activity and hedge fund positioning around the earnings announcement are being tracked by market participants ahead of the Q1 2027 results release.
Summary
Tilray Brands is preparing to announce Q1 2027 financial results on October 8, 2026, following the market close. Consensus analyst expectations call for a per-share loss of $0.1640 against revenue of approximately $267.77 million, according to MarketBeat. The company will conduct an earnings call at 8:30 AM EDT on the announcement date, with webcast access and full transcript availability provided to investors and analysts.

The earnings announcement arrives on the heels of record performance in fiscal 2026, where Tilray demonstrated operational momentum across its diversified business platform. The company has successfully integrated cannabis, beverage, hospitality, and wellness operations into a cohesive global consumer goods enterprise. Q3 fiscal 2026 results highlighted the company's trajectory, with net revenue reaching $207 million and gross profit expanding 6% year-over-year to $55 million, supported by 11% organic growth during that period.

Tilray Brands (NASDAQ: TLRY; TSX: TLRY) operates as a global lifestyle and consumer packaged goods company, with dual listings reflecting its North American footprint and strategic positioning. Market participants are monitoring insider transactions and hedge fund activity ahead of the Q1 2027 earnings release, as institutional investors assess the company's near-term financial trajectory and management execution across its beverage and cannabis verticals.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Quiver Quantitative TILRAY Q1 2027 Earnings Preview: Recent $TLRY Insider Trading, Hedge Fund Activity, and More